Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Juridische Perikelen rond SNS-onteigening.
Volgen
8 juni cassatie niet ontvankelijk
johhan schreef op 19 mei 2021 10:03 :
8 juni cassatie niet ontvankelijk
Waar slaat dat op....???
kennis is advocaat geeft 2 derde kans
o nee is 1 op drie nul mijn pensioen bij fnv weg
johhan schreef op 19 mei 2021 10:03 :
8 juni cassatie niet ontvankelijk
En nu in het Nederlands...
Ik vermoed dat ze wel willen uitbetalen maar alleen in natura: mondkapjes. nos.nl/l/2381368
HAHAHA... ja ach een bonnetje meer of minder maakt toch niets uit. Tjonge jonge en deze deskundige gaan in Cassatie omdat ze geen idee hebben waarom ze in Cassatie moeten gaan. STUMPERS.
Ik vind het onrustwekkend dat we na een week nog steeds niet weten waarop het cassatieberoep van de minister gebaseerd is. Transparantie?
Of je het wel of niet weet; dat gaat geen enkel verschil maken.
Als je lid bent van de VEB kun je die stukken gewoon opvragen bij de VEB. Die procedeert namens jou en in die zin ben je partij. De rest is nieuwsgierigheid of je moet zo goed ingevoerd zijn dat je de technische kans op een geslaagde cassatie redelijk kunt inschatten. Hoekstra wil straks gewoon in de Kamer kunnen zeggen: we hebben alle rechtsmiddelen benut en uitgeput, maar helaas moeten we doen wat de rechters ons hebben opgelegd. Dat wederom (ook) een flink aantal burgers in dit proces gedurende 10 jaar de hen toekomende schadeloosstelling (welke deels hun pensioenaanvulling was) wordt ontzegd, is van het type toeslagen affaire schoffering. Wees dan als overheid een betrouwbare partij en keer alvast (deels) uit. Je hebt de bsn nummers van die mensen dus je kunt via de fiscus altijd weer terugvorderen in de zeer onwaarschijnlijke situatie dat de Hoge Raad ineens alles van tafel zou vegen en alles op nihil zou houden. Die kans acht ik bijzonder klein, zeker gezien de eerder uitspraak in de Hoge Raad in deze casus.
objectief schreef op 20 mei 2021 09:23 :
Of je het wel of niet weet; dat gaat geen enkel verschil maken.
Ik ben blij voor jou dat jij tevreden bent met je onwetendheid. Ik volg graag mijn zaakjes van iets dichterbij op. Dat zijn verschillende levenshoudingen en daar is niets mis mee.
"Reden voor het [cassatie]beroep is dat de staat het bedrag te hoog vindt, en het niet helemaal eens is met de redenering van de Ondernemingskamer" Lijken me geen cassatiegronden.www.accountant.nl/nieuws/2021/5/staat...
Foundation SOS SNS Dear all, As promised I would submit some comments on the cassation-saga. Not only the Dutch State but also the ‘Stichting Beheer’ (the largest shareholder and subordinated creditor) has filed a cassation-request. In order to understand the procedure properly, first a short remark on the essence of a cassation In the cassation the ‘facts’ that the judges from the Enterprise Chamber have established, can’t be challenged anymore. E.g. the verdict that in the case the Nationalization on February 1st 2013 would not have taken place, SNS would have gone bankrupt, is no longer debateable anymore. It is also not allowed to simply state e.g. that the valuation of the expropriated bonds is ‘too high’or ‘too low’. Technically speaking the High Council evaluates the verdict of the Enterpice Chamber on two grounds: a. Did the Enterprise Chamber apply the right laws? b. Did the Enterprise Chamber apply the laws in a right manner? Apart from that the High Council takes into account the way the motivation of the decision was grounded. Did the Enterpise Chamber motivate their verdict in an understandable, adequate, comprehensive and complete manner? The Dutch State has filed a document of more than 100 pages (!) in which they try to scutinize the report from the experts as well as the way in which the Enterprise Chamber incorporated the results into their final verdict. It is of course not possible to simply state that the figures the experts have used are incorrect (because these are considered as ‘facts’ or ‘outcomes’). However it can be argued that the assumptions, that have led to the outcomes, are ‘incorrect’, ‘not understandable’ and/or ‘badly grounded’. Without going into too much detail, examples of challenging the assumption are: a. The length of the period the liquidator takes to unwind the business (especially mortgages) and after that period sells the portfolio, but also which factor should be used to discount future cash flows (i.e. to recalculate these cash flows towards february 1 2013). b. Furthermore the Dutch State argues that the experts wrongly make use of case law (e.g. the DSB Bank whereby subordinated creditors revceived a compensation of 100%), because the situation of SNS is in the opinion of the Dutch State not comparable. c. Finally they blame the experts, because in the opinion of the Dutsch State they have judged with ‘hindsight bias’ (the financial results from SNS after february 1 2013 were very robust and this have influenced the judgement of the experts, according to the State). De Dutch State concludes that it is al lto arbitrary and random, badly grounded etc. and they ask the High Council to annul the verdict, which implies that the Enterprise Chamber should start áll over again’. In that case, however, the High Council would submit clues on how the expert’s report should be moderated. This will of course not take another eight years, but as you have experienced in legal cases a few years is ‘nothing’. The ‘Stichting Beheer’ (shareholder and subordinated creditor) complaints that the the subordinated loans they have given to SNS Bank are inadequately considered as shares, which implies that the Stichting Beheer is not entitled to any compensation. As you might recall the value of the shares is considered to be zero, while the value of the bond excluding legal interest is 75% of the nominal value, and because none of the shareholders has filed a cassation request, this outcome fort he shareholders is now final. For us, the outcome of the evaluation by the High Council is not so relevant, because any compensation for the ‘Stichting Beheer’ will hardly influence the amont available for your bonds. It is almost impossible to predict what the decision of the High Council will be, but my preliminary reaction is that it might be quiet easy for the High Council to set aside all the complaints, given the fact that the valuation process has been carefully carried out (in every situation it is inevitable that you must make choices), the experts have demonstrated adequate professionalism in performing their task and they appear to be really independent. Furthermore the hearing has been fair (adversarial practice). Please realize that this is only my opinion before consulting experts, so any guarantee that this will be the final outcome, can not be deployed. A final remark on the future of your foundation and its services seems to be relevant. When I accepted the position as chairman of this foundation at the end of January 2013, I could not have foreseen that in May 2021 we still would not have a final verdict and a proper compensation. This goes without saying alsof or all participants in your foundation. Currently we have to make a decision wether to actively participate in the cassation, which of course will require a new effort for a longer period of time. The risk that the High Council eventually will annul the verdict is still there and it is not unthinkable that it will last another 1,5-2 years untill that is clear. In the case the decision leads to an anullment, we might have to wait another few years until the final verdict from the Enterprise Chamber is submitted. However this is a dark scenario and procedures can be a lot shorter/faster. I consider this therefore as a natural moment to decide under which conditions we will enter this new set of procedures. Don’t be affraid that I will step down but I think it is a good idea to organize my thoughts on this subject and give you feedback as soon as possible. The most important factor is how the foundation could be effective as possible and have a real added value.
Marco 2019 schreef op 2 juni 2021 22:48 :
Foundation SOS SNS Dear all,
...
The Dutch State has filed a document of more than 100 pages (!) ....
Is it possible to share that document?
Marco 2019 schreef op 2 juni 2021 22:48 :
Foundation SOS SNS Dear all,
Which part of"Strikt vertrouwelijk (dus niet in het forum van IEX of elders plaatsen s.v.p.)" did you not understand Marco? Het feit dat je het door google translate haalt verandert hier volgens mij niks aan.
sorry can you delete my message? I can not do it.
Marco 2019 schreef op 3 juni 2021 10:10 :
sorry can you delete my message?
I can not do it.
TE Laat...!!
Is there a Moderator or Administrator to ask for the deletion of the message?
Marco 2019 schreef op 3 juni 2021 12:04 :
Is there a Moderator or Administrator to ask for the deletion of the message?
Dat heeft geen zin meer; het is al vele malen gekopieerd.
Wel jammer dat niet is te zien of de oorspronkelijke tekst (van meneer Faas?) minder onzinnig is dan die van Google T.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
920,07
-0,39%
EUR/USD
1,0738
-0,33%
FTSE 100
8.216,83
-0,35%
Germany40^
18.433,30
-0,67%
Gold spot
2.298,28
+0,20%
NY-Nasdaq Composite
17.133,13
-0,23%
Stijgers
Dalers